Wendall Wierenga insider trades
Open-market stock purchases and sales by Wendall Wierenga, Director at Cytokinetics Inc, from SEC Form 4 filings since Mar 31, 2010.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- CYTK Cytokinetics Inc: 11 sales, last Jul 15, 2025
- CRNX Crinetics Pharmaceuticals, Inc: other filings, last Jun 11, 2025
- CNCE Concert Pharmaceuticals, Inc: other filings, last Jun 14, 2018
- APRI Apricus Biosciences, Inc: 1 buy, last Jan 4, 2018
- OCRX Ocera Therapeutics, Inc: 1 buy, last Dec 11, 2017
- XNPT Xenoport Inc: 2 buys, last Jul 5, 2016
- ANAC Anacor Pharmaceuticals, Inc: other filings, last Jun 24, 2016
- SNTS Santarus Inc: other filings, last Jan 2, 2014
- ONXX Onyx Pharmaceuticals Inc: 9 sales, last Oct 1, 2013